'Viral vectors' presentation slideshows

Drug Delivery Systems

Drug Delivery Systems. ??? - ????? ?????????????????? 12 ? 25 ??? 2:30 ??? : 18 ??? 1 ? ???????? : ????????? ?????????????????? 12 ? 27 ??? 8:30 ??? : 18 ??? 1 ?. Content. Introduction to Drug Delivery Systems (DDSs) Mechanisms of Polymer-based DDSs Progress in DDSs

1.26k views • 93 slides

Viral Vector Training

Viral Vector Training. Viral Vectors. Can be used as gene delivery systems Can also be used for human gene therapy All work with viral vectors must be registered with the campus Institutional Biosafety Committee (IBC) Prokaryotic or Eukaryotic viruses:

1.08k views • 66 slides

New Strategies Towards Vaccine Design Challenging HIV

New Strategies Towards Vaccine Design Challenging HIV. Ralf Wagner Univ. Prof. for Medical Microbiology and Gene Therapy, University of Regensburg. Starting point. Targets of immune response. envelope proteins: Env structural proteins: Gag, Pol regulatory proteins: Tat, Rev, Nef

704 views • 58 slides

BioSafety Considerations

BioSafety Considerations. For Viral Vectors. Biosafety Considerations of Viral Vectors. Lifestyles of the Small & Infectious Terminology of Gene Expression Viruses to Vectors Vectors and More Vectors. Lifestyles of the Small and Infectious. Very Basic Virology. What Are Viruses?.

781 views • 52 slides

Peter J. Nigro, MD, MPH

Peter J. Nigro, MD, MPH. Occupational Health Challenges of working in Lab Animal Research: Viral Vector Exposures & Animal Allergies. Introducing nucleic acids into cells. Purpose (research; clinical) Methods Non-viral Viral Viral Retroviruses

573 views • 47 slides

TOPICS IN (NANO) BIOTECHNOLOGY Gene Therapy Lecture 11

PhD Course. TOPICS IN (NANO) BIOTECHNOLOGY Gene Therapy Lecture 11. 2nd June, 2006. What is gene therapy? Why is it used?. Gene therapy is the application of genetic principles in the treatment of human disease

680 views • 42 slides

AIDS Vaccines Advancing Development through Innovation

AIDS Vaccines Advancing Development through Innovation. Frans van den Boom Vice President IAVI European Programmes 24 October 2007 Helsinki, Finland. Understanding global inequalities. Private health spending. Malaria cases. 2.

494 views • 39 slides

MALARIA VACCINES A tale of two vaccines (and more)

515 views • 34 slides

Recombinant Baculovirus :

Recombinant Baculovirus :. A Potential Vector for Cancer Gene Therapy Jenna Kausner November 4, 2010. Conventional Cancer Therapeutics. Surgical resection of primary tumor Chemotherapy Inefficient- unable to control metastasized tumors and promote long-term survival.

651 views • 29 slides

Diversity of Living Things

Diversity of Living Things. 2.2 Viruses p. 54-59 Nelson Biology 11. What is a Virus?. Microscopic particles capable of reproducing only within living cells Lifeless outside of living cells, in living cells (host cell) they can reproduce. Virus means poison in Latin.

868 views • 23 slides

CALIXARENE-BASED NANOSYSTEMS FOR GENE DELIVERY

473 views • 23 slides

Martha Lewis Blum, M.D. Ph.D. August 27, 2013

HIV Vaccine. Martha Lewis Blum, M.D. Ph.D. August 27, 2013. Review of Vaccination history (3 slides) how should it work (5 slides). Approaches to an HIV Vaccine goals of vaccination (1 slide) current approaches (5 slides). Highly Publicized HIV Vaccine Trials

327 views • 21 slides

Gene Therapy

Gene Therapy. Molecular genetics presentation Made by / Mostafa Ahmed Supervisor Dr / Noha Khalifa. Introduction. Imagine that you accidentally broke one of your neighbor's windows. What would you do? You could:

797 views • 20 slides

Cystic Fibrosis

PHM142 Fall 2013 Coordinator: Dr. Jeffrey Henderson Instructor: Dr. David Hampson. Cystic Fibrosis . Katalina Chan, Mary Vu, Sunny Wang and Vanessa Alexander Nov 4, 2013. Background. 80,000 CF patients Mutation in CFTR gene E pithelial cells at mucosal surfaces

323 views • 18 slides

GENE THERAPY

GENE THERAPY. In humans. Cancer 69%. The Food and Drug Administration (FDA) has not yet approved any human gene therapy product for sale. 2) Immune response . It reduces gene therapy effectiveness and makes repetitive rounds of gene therapy useless.

523 views • 18 slides

Viral Vector and Non-viral Vector

Viral Vector and Non-viral Vector . Viral Life cycle . Infection Phase Replication Phase . Gene transfer strategies.

724 views • 17 slides

280 views • 15 slides

Carl W. Dieffenbach , Ph.D. Director Division of AIDS, NIAID July 2, 2013

HIV Vaccine and Future Strategies . Carl W. Dieffenbach , Ph.D. Director Division of AIDS, NIAID July 2, 2013. This session will review past HIV vaccine efforts, as well as novel viral vectors and advances in the design of vaccines to induce neutralizing antibodies.

226 views • 11 slides

Molecular Biology

315 views • 7 slides

Integrating viral vectors*

SAFETY. EFFICIENCY. Integrating viral vectors*. Excisable viral vectors*. Reprogramming proteins. piggyBac transposon. Non-integrating vectors. Eliminates risks associated with genome modification; non-DNA approach Very slow process.

188 views • 1 slides